Improving Drug Supply Chain Security

Affiliations

¹ University of Maryland School of Medicine, Baltimore.
² Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
³ Program On Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Free article

Joseph T Kannarkat et al. JAMA Health Forum. 2024.

Free article

. 2024 Jan 5;5(1):e234819.

doi: 10.1001/jamahealthforum.2023.4819.

¹ University of Maryland School of Medicine, Baltimore.
² Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
³ Program On Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

No abstract available

Plain language summary

This Viewpoint discusses the importance of the Drug Supply Chain Security Act and the need for pharmaceutical supply chain safeguards.